2019•Neuromuscular DisordersRequires access

P.71The emerging phenotype in long-term enzyme-treated classic infantile Pompe patients: severe distal muscle weakness

J. van den Dorpel, Esther Poelman, Laurike Harlaar, H. van Kooten, Lianne van der Giessen, P. van Doorn, A. van der Ploeg, J. van den Hout, N. van der Beek

Open publisher page 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Weakness, Medicine, Proximal muscle weakness, Muscle weakness, Myopathy, Congenital myopathy, Glycogen storage disease type II, Enzyme replacement therapy

Back to paper search Browse research topics Original source

P.71The emerging phenotype in long-term enzyme-treated classic infantile Pompe patients: severe distal muscle weakness — Research Paper | ScholarLens